Sanwo-Olu, during a media briefing on Sunday, expressed concern over the increasing number of cases in the state and hinted that there is a potential third wave in Lagos.
The Governor of Lagos State, Babajide Sanwo-Olu, has said the isolation centres in the state earmarked for the COVID-19 treatment are getting occupied again.According to him, the isolation centres have recorded a five per cent increase in occupancy in two weeks.“From the beginning of July, we started to experience a steep increase in the number of daily confirmed cases, with the test positivity rate going from 1.
1% at the end of June 2021 to its current rate of 6.6% as at 8th of July 2021.“The rapid increase within a week gives great cause for concern. Also, within the last two weeks, the occupancy rate at our two isolation centres increased from an average of one per cent to six per cent,” Sanwo-Olu said.This comes barely two days after the Nigeria Centre for Disease Control said it had detected a confirmed case with the SARS-CoV-2 Delta variant, also known as lineage B.1.617.2.
Nigeria Latest News, Nigeria Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
COVID-19: Nigeria records 186 new cases – NCDC | The Guardian Nigeria News - Nigeria and World NewsThe Nigeria Centre for Diseases Control (NCDC) has registered 186 new cases of coronavirus (COVID-19) infections from three states.
Read more »
COVID-19 impact on tourism: Global economy could lose over $4 trillionEconomic losses are mounting in developing countries due to the absence of widespread COVID-19 vaccinations. According to UNCTAD
Read more »
COVID-19: Ekiti alerts residents on Delta variant, heightens protocol enforcement - Punch NewspapersThe most widely read newspaper in Nigeria
Read more »
WHO insists COVID-19 vaccines outweigh risksMyocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart.
Read more »
Myocarditis side effect: WHO insists COVID-19 vaccines outweigh risks
Read more »